BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20942896)

  • 1. Plasma testosterone and sex hormone-binding globulin concentrations and the risk of prostate cancer among Japanese men: a nested case-control study.
    Sawada N; Iwasaki M; Inoue M; Sasazuki S; Yamaji T; Shimazu T; Tsugane S;
    Cancer Sci; 2010 Dec; 101(12):2652-7. PubMed ID: 20942896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of sex hormone levels and risk of prostate cancer.
    Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
    J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition.
    Travis RC; Key TJ; Allen NE; Appleby PN; Roddam AW; Rinaldi S; Egevad L; Gann PH; Rohrmann S; Linseisen J; Pischon T; Boeing H; Johnsen NF; Tjønneland A; Overvad K; Kiemeney L; Bueno-de-Mesquita HB; Bingham S; Khaw KT; Tumino R; Sieri S; Vineis P; Palli D; Quirós JR; Ardanaz E; Chirlaque MD; Larrañaga N; Gonzalez C; Sanchez MJ; Trichopoulou A; Bikou C; Trichopoulos D; Stattin P; Jenab M; Ferrari P; Slimani N; Riboli E; Kaaks R
    Int J Cancer; 2007 Sep; 121(6):1331-8. PubMed ID: 17514649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada.
    Wu AH; Whittemore AS; Kolonel LN; John EM; Gallagher RP; West DW; Hankin J; Teh CZ; Dreon DM; Paffenbarger RS
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):735-41. PubMed ID: 8672990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgens and prostate cancer risk: a prospective study.
    Wirén S; Stocks T; Rinaldi S; Hallmans G; Bergh A; Stenman UH; Kaaks R; Stattin P
    Prostate; 2007 Aug; 67(11):1230-7. PubMed ID: 17562541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasectomy and prostate cancer: results from a multiethnic case-control study.
    John EM; Whittemore AS; Wu AH; Kolonel LN; Hislop TG; Howe GR; West DW; Hankin J; Dreon DM; Teh CZ
    J Natl Cancer Inst; 1995 May; 87(9):662-9. PubMed ID: 7538594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of sex hormone-binding globulin and sex hormones on risk of incident type 2 diabetes.
    Hu J; Zhang A; Yang S; Wang Y; Goswami R; Zhou H; Zhang Y; Wang Z; Li R; Cheng Q; Zhen Q; Li Q
    J Diabetes; 2016 Jul; 8(4):508-15. PubMed ID: 26119029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both total testosterone and sex hormone-binding globulin are independent risk factors for metabolic syndrome: results from Fangchenggang Area Male Health and Examination Survey in China.
    Zhang J; Huang X; Liao M; Gao Y; Tan A; Yang X; Zhang H; Mo L; Zhang Y; Lu Z; Wu C; Hu Y; Mo Z
    Diabetes Metab Res Rev; 2013 Jul; 29(5):391-7. PubMed ID: 23463406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.
    Stattin P; Lumme S; Tenkanen L; Alfthan H; Jellum E; Hallmans G; Thoresen S; Hakulinen T; Luostarinen T; Lehtinen M; Dillner J; Stenman UH; Hakama M
    Int J Cancer; 2004 Jan; 108(3):418-24. PubMed ID: 14648709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Concentrations of Sex Hormone-binding Globulin Vary Widely in Younger and Older Men: Clinical Data from a Men's Health Practice.
    Krakowsky Y; Conners W; Morgentaler A
    Eur Urol Focus; 2019 Mar; 5(2):273-279. PubMed ID: 28753796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous sex hormones and the risk of prostate cancer: a prospective study.
    Weiss JM; Huang WY; Rinaldi S; Fears TR; Chatterjee N; Hsing AW; Crawford ED; Andriole GL; Kaaks R; Hayes RB
    Int J Cancer; 2008 May; 122(10):2345-50. PubMed ID: 18172860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of sex hormone-binding globulin and testosterone with diabetes among men and women (the Saku Diabetes study): a case control study.
    Goto A; Morita A; Goto M; Sasaki S; Miyachi M; Aiba N; Terauchi Y; Noda M; Watanabe S;
    Cardiovasc Diabetol; 2012 Oct; 11():130. PubMed ID: 23066943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: a longitudinal study.
    Heikkilä R; Aho K; Heliövaara M; Hakama M; Marniemi J; Reunanen A; Knekt P
    Cancer; 1999 Jul; 86(2):312-5. PubMed ID: 10421267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study.
    Gapstur SM; Gann PH; Kopp P; Colangelo L; Longcope C; Liu K
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1041-7. PubMed ID: 12376505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous androgens and risk of epithelial ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Rinaldi S; Dossus L; Lukanova A; Peeters PH; Allen NE; Key T; Bingham S; Khaw KT; Trichopoulos D; Trichopoulou A; Oikonomou E; Pera G; Larrañaga N; Martinez-Garcia C; Ardanaz E; Quirós JR; Tormo MJ; Tjønneland A; Olsen A; Overvad K; Chang-Claude J; Linseisen J; Schulz M; Boeing H; van Gils CH; Bueno-de-Mesquita BH; Pala V; Palli D; Panico S; Tumino R; Vineis P; Clavel-Chapelon F; Mesrine S; Boutron-Ruault MC; Lundin E; Agren A; Berglund G; Manjer J; Kumle M; Lund E; Slimani N; Saracci R; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):23-9. PubMed ID: 17220328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interrelationships between plasma testosterone, SHBG, IGF-I, insulin and leptin in prostate cancer cases and controls.
    Kaaks R; Lukanova A; Rinaldi S; Biessy C; Söderberg S; Olsson T; Stenman UH; Riboli E; Hallmans G; Stattin P
    Eur J Cancer Prev; 2003 Aug; 12(4):309-15. PubMed ID: 12883384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premenopausal serum androgens and breast cancer risk: a nested case-control study.
    Zeleniuch-Jacquotte A; Afanasyeva Y; Kaaks R; Rinaldi S; Scarmo S; Liu M; Arslan AA; Toniolo P; Shore RE; Koenig KL
    Breast Cancer Res; 2012 Feb; 14(1):R32. PubMed ID: 22339988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial.
    Schenk JM; Till C; Hsing AW; Stanczyk FZ; Gong Z; Neuhouser ML; Reichardt JK; Hoque AM; Figg WD; Goodman PJ; Tangen CM; Thompson IM
    Cancer Causes Control; 2016 Feb; 27(2):175-82. PubMed ID: 26589415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Levels of Androgens, Estrogens, and Sex Hormone Binding Globulin and Risk of Primary Gastric Cancer in Chinese Men: A Nested Case-Control Study.
    Zhu Z; Chen Y; Ren J; Dawsey SM; Yin J; Freedman ND; Fan JH; Taylor PR; Liu Y; Qiao YL; Abnet CC
    Cancer Prev Res (Phila); 2021 Jun; 14(6):659-666. PubMed ID: 33766833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.